Epidermal growth factor receptor pathway substrate 8 (Eps8) was initially identified as the substrate for the kinase activity of EGFR, improving the responsiveness of EGF, which is involved in cell mitosis, differentiation and other physiological functions. Numerous studies over the last decade have demonstrated that Eps8 is overexpressed in most ubiquitous malignant tumours and subsequently binds with its receptor to activate multiple signalling pathways. Eps8 not only participates in the regulation of malignant phenotypes, such as tumour proliferation, invasion, metastasis and drug resistance, but is also related to the clinicopathological characteristics and prognosis of patients. Therefore, Eps8 is a potential tumour diagnosis and prognostic biomarker and even a therapeutic target. This review aimed to describe the structural characteristics, role and related molecular mechanism of Eps8 in malignant tumours. In addition, the prospect of Eps8 as a target for cancer therapy is examined.
CITATION STYLE
Luo, K., Zhang, L., Liao, Y., Zhou, H., Yang, H., Luo, M., & Qing, C. (2021, March 1). Effects and mechanisms of Eps8 on the biological behaviour of malignant tumours (Review). Oncology Reports. Spandidos Publications. https://doi.org/10.3892/or.2021.7927
Mendeley helps you to discover research relevant for your work.